There are major investment opportunities right now in health care, which "stands at the threshold of a real sea change," the head of Google's venture capital investment arm told CNBC on Monday.
Just as the conversion from vacuum tubes to microprocessors spurred innovation and made things like the Apple iPhone and Google Android possible, similar developments are happening in health, Google Ventures' Bill Maris said on "Squawk Alley."
"Health care stands at that crossroads now where we can read genomic information in a way that 10 years ago was impossible, so I think you'll see an even more significant change over the next 10 years in health care than we've seen probably in the last 50," he said.
Maris was referring to the Human Genome Project, which took roughly 10 years and billions of dollars to determine the makeup of DNA and map all of the genes of the human genome. Today, however, an entire genome can be sequenced in hours for only about $1,000, he said.
"And that's only in the last 10 years, so you're going to see something really special happen over the next 10 years," he said.
In turn, Maris sees investment opportunities in companies that handle everything from diagnostics to delivery systems and distribution.
Currently, Google Ventures backs a number of health-related start-ups with the common thread of "where technology and big data intersect with health care," he said.